s NPS Media Releases February 2010 | I2P: Information to Pharmacists - Archive
Publication Date 01/07/2014         Volume. 6 No. 6   
Information to Pharmacists

Editorial

From the desk of the editor

Welcome to the July 2014 homepage edition of i2P (Information to Pharmacists) E-Magazine.
At the commencement of 2014 i2P focused on the need for the entire profession of pharmacy and its associated industry supports to undergo a renewal and regeneration.
We are now half-way through this year and it is quite apparent that pharmacy leaders do not yet have a cohesive and clear sense of direction.
Maybe the new initiative by Woolworths to deliver clinical service through young pharmacists and nurses may sharpen their focus.
If not, community pharmacy can look forward to losing a substantial and profitable market share of the clinical services market.
Who would you blame when that happens?
But I have to admit there is some effort, even though the results are but meagre.
In this edition of i2P we focus on the need for research about community pharmacy, the lack of activity from practicing pharmacists and when some research is delivered, a disconnect appears in its interpretation and implementation.

read more
open full screen

Recent Comments

Click here to read...

News Flash

Newsflash Updates for July 2014

Newsflash Updates

Regular weekly updates that supplement the regular monthly homepage edition of i2P. 
Access and click on the title links that are illustrated

Comments: 1

read more
open full screen

Feature Contribution

Woolworths Pharmacy - Getting One Stage Closer

Neil Johnston

It started with “tablet” computers deployed on shelves inside the retailer Coles, specifically to provide information to consumers relating to pain management and the sale of strong analgesics.
This development was reported in i2P under the title Coles Pharmacy Expansion and the Arid PGA Landscape”
In that article we reported that qualified information was a missing link that had come out of Coles market research as the reason to why it had not succeeded in dominating the pain market.
Of course, Woolworths was working on the same problem at the same time and had come up with a better solution - real people with good information.

Comments: 5

read more
open full screen

Intensive Exposition without crossing over with a supermarket

Fiona Sartoretto Verna AIAPP

Editor's Note: The understanding of a pharmacy's presentation through the research that goes into the design of fixtures and fittings that highlight displays, is a never-ending component of pharmacy marketing.
Over the past decade, Australian pharmacy shop presentations have fallen behind in standards of excellence.
It does not take rocket science - you just have to open your eyes.
Recently, our two major supermarkets, Woolworths and Coles, have entered into the field of drug and condition information provision - right into the heartland of Australian Pharmacy.

read more
open full screen

The sure way to drive business away

Gerald Quigley

I attended the Pregnancy, Baby and Children’s Expo in Brisbane recently.
What an eye and ear opening event that was!
Young Mums, mature Mums, partners of all ages, grandparents and friends……...many asking about health issues and seeking reassurances that they were doing the right thing.

Comments: 1

read more
open full screen

‘Marketing Based Medicine’ – how bad is it?

Baz Bardoe

It should be the scandal of the century.
It potentially affects the health of almost everyone.
Healthcare providers and consumers alike should be up in arms. But apart from coverage in a few credible news sources the problem of ‘Marketing Based Medicine,’ as psychiatrist Dr Peter Parry terms it, hasn’t as yet generated the kind of universal outrage one might expect.

read more
open full screen

Community Pharmacy Research - Are You Involved?

Mark Coleman

Government funding is always scarce and restricted.
If you are ever going to be a recipient of government funds you will need to fortify any application with evidence.
From a government perspective, this minimises risk.
I must admit that while I see evidence of research projects being managed by the PGA, I rarely see community pharmacists individually and actively engaged in the type of research that would further their own aims and objectives (and survival).

read more
open full screen

Organisational Amnesia and the Lack of a Curator Inhibits Cultural Progress

Neil Johnston

Most of us leave a tremendous impact on pharmacies we work for (as proprietors, managers, contractors or employees)—in ways we’re not even aware of.
But organisational memories are often all too short, and without a central way to record that impact and capture the knowledge and individual contributions, they become lost to time.
It is ironic that technology has provided us with phenomenal tools for communication and connection, but much of it has also sped up our work lives and made knowledge and memory at work much more ephemeral.

read more
open full screen

Academics on the payroll: the advertising you don't see

Staff Writer

This article was first published in The Conversation and was written by Wendy Lipworth, University of Sydney and Ian Kerridge, University of Sydney
In the endless drive to get people’s attention, advertising is going ‘native’, creeping in to places formerly reserved for editorial content. In this Native Advertising series we find out what it looks like, if readers can tell the difference, and more importantly, whether they care.
i2P has republished the article as it supports our own independent and ongoing investigations on how drug companies are involved in marketing-based medicine rather than evidence-based medicine.

read more
open full screen

I’ve been thinking about admitting wrong.

Mark Neuenschwander

Editor's Note: This is an early article by Mark Neuenschwander we have republished after the soul-searching surrounding a recent Australian dispensing error involving methotrexate.
Hmm. There’s more than one way you could take that, huh? Like Someday when I get around to it (I’m not sure) I may admit that I was wrong about something. Actually, I’ve been thinking about the concept of admitting wrong. So don’t get your hopes up. No juicy confessions this month except that I wish it were easier for me to admit when I have been wrong or made a mistake.
Brian Goldman, an ER physician from Toronto, is host of the award-winning White Coat, Black Art on CBC Radio and slated to deliver the keynote at The unSUMMIT for Bedside Barcoding in Anaheim this May. His TED lecture, entitled, “Doctors make mistakes. Can we talk about it?” had already been viewed by 386,072 others before I watched it last week.

read more
open full screen

Dispensing errors – a ripple effect of damage

Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA

Most readers will be aware of recent publicity relating to dispensing errors and in particular to deaths caused by methotrexate being incorrectly packed in dose administration aids.
The Pharmacy Board of Australia (PBA), in its Communique of 13 June 2014, described a methotrexate packing error leading to the death of a patient and noted “extra vigilance is required to be exercised by pharmacists with these drugs”.
This same case was reported by A Current Affair (ACA) in its program on Friday 20 June
http://aca.ninemsn.com.au/article/8863098/prescription-drug-warning

read more
open full screen

Take a vacation from your vocation

Harvey Mackay

Have you ever had one of those days when all you could think was, “Gosh, do I need a vacation.”
Of course you have – because all work and no play aren’t good for anyone.
A vacation doesn’t have to be two weeks on a tropical island, or even a long weekend at the beach. 
A vacation just means taking a break from your everyday activities. 
A change of pace. 
It doesn’t matter where.
Everyone needs a vacation to rejuvenate mentally and physically. 
But did you also know that you can help boost our economy by taking some days off? 
Call it your personal stimulus package.

read more
open full screen

Explainer: what is peer review?

Staff Writer

This article was first published in the Conversation. It caught our eye because "peer review" it is one of the standards for evidence-based medicines that has also been corrupted by global pharma.
The article is republished by i2P as part of its ongoing investigation into scientific fraud and was writtenby Andre Spicer, City University London and Thomas Roulet, University of Oxford
We’ve all heard the phrase “peer review” as giving credence to research and scholarly papers, but what does it actually mean?
How does it work?
Peer review is one of the gold standards of science. It’s a process where scientists (“peers”) evaluate the quality of other scientists' work. By doing this, they aim to ensure the work is rigorous, coherent, uses past research and adds to what we already knew.
Most scientific journals, conferences and grant applications have some sort of peer review system. In most cases it is “double blind” peer review. This means evaluators do not know the author(s), and the author(s) do not know the identity of the evaluators.
The intention behind this system is to ensure evaluation is not biased.
The more prestigious the journal, conference, or grant, the more demanding will be the review process, and the more likely the rejection. This prestige is why these papers tend to be more read and more cited.

read more
open full screen

Dentists from the dark side?

Loretta Marron OAM BSc

While dining out with an elderly friend, I noticed that he kept his false tooth plate in his shirt pocket. He had recently had seven amalgam-filled teeth removed, because he believed that their toxins were making him sick; but his new plate was uncomfortable. He had been treated by an 'holistic dentist'. Claiming to offer a "safe and healthier alternative" to conventional dentistry, are they committed to our overall health and wellbeing or are they promoting unjustified fear, unnecessarily extracting teeth and wasting our money?

read more
open full screen

Planning for Profit in 2015 – Your key to Business Success

Chris Foster

We are now entering a new financial year and it’s a great time to reflect on last year and highlight those things that went well and those that may have impacted negatively in the pursuit of your goals.
It's also a great to spend some time re-evaluating your personal and business short, medium and long term goals in the light of events over the last year.
The achievement of your goals will in many cases be dependent on setting and aspiring to specific financial targets. It's important that recognise that many of your personal goals will require you to generate sufficient business profits to fund those aspirations

read more
open full screen

ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use

Staff Writer

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.

read more
open full screen

Attracting and Retaining Great People

Barry Urquhart

Welcome to the new financial year in Australia.
For many in business the past year has been described as a challenging period.
Adjectives are a key feature of the English language.  In the business lexicon their use can be, and often is evocative and stimulate creative images.  But they can also contribute to inexact, emotional perceptions.
Throughout the financial pages of newspapers and business magazines adjectives abound.
References to “hot” money draw attention and comment.  The recent wave of funds from Chinese investors, keen to remove their wealth from the jurisdiction and control of government regulations is creating a potential property bubble in Australia.

read more
open full screen

Updating Your Values - Extending Your Culture

Neil Johnston

Pharmacy culture is dormant.
Being comprised of values, unless each value is continually addressed, updated or deleted, entire organisations can stagnate (or entire professions such as the pharmacy profession).
Good values offer a strong sense of security, knowing that if you operate within the boundaries of your values, you will succeed in your endeavours.

read more
open full screen

Evidence-based medicine is broken. Why we need data and technology to fix it

Staff Writer

The following article is reprinted from The Conversation and forms up part of our library collection on evidence-based medicines.
At i2P we also believe that the current model of evidence is so fractured it will never be able to be repaired.
All that can happen is that health professionals should independently test and verify through their own investigations what evidence exists to prescribe a medicine of any potency.
Health professionals that have patients (such as pharmacists) are ideally placed to observe and record the efficacy for medicines.
All else should confine their criticisms to their evidence of the actual evidence published.
If there are holes in it then share that evidence with the rest of the world.
Otherwise, do not be in such a hurry to criticise professions that have good experience and judgement to make a good choice on behalf of their patients, simply because good evidence has not caught up with reality.

read more
open full screen

Laropiprant is the Bad One; Niacin is/was/will always be the Good One

Staff Writer

Orthomolecular Medicine News Service, July 25, 2014
Laropiprant is the Bad One; Niacin is/was/will always be the Good One
by W. Todd Penberthy, PhD

(OMNS July 25, 2014) Niacin has been used for over 60 years in tens of thousands of patients with tremendously favorable therapeutic benefit (Carlson 2005).
In the first-person NY Times best seller, "8 Weeks to a Cure for Cholesterol," the author describes his journey from being a walking heart attack time bomb to a becoming a healthy individual.
He hails high-dose niacin as the one treatment that did more to correct his poor lipid profile than any other (Kowalski 2001).

read more
open full screen

Culture Drive & Pharmacy Renewal

Neil Johnston

Deep within all of us we have a core set of values and beliefs that create the standards of behaviour that we align with when we set a particular direction in life.
Directions may change many times over a lifetime, but with life experiences and maturity values may increase in number or gain greater depth.
All of this is embraced under one word – “culture”.
When a business is born it will only develop if it has a sound culture, and the values that comprise that culture are initially inherent in the business founder.
A sound business culture equates to a successful business and that success is often expressed in the term “goodwill” which can be eventually translated to a dollar value.

read more
open full screen

ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use

Staff Writer

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.

read more
open full screen

Pharmacy 2014 - Pharmacy Management Conference

Neil Johnston

The brave new world of health and wellness is not the enemy of Pharmacy, it is its champion.
Australian futurist, Morris Miselowski, one of the world's leading business visionaries, will present the Opening Keynote address on Pharmacy's Future in the new Health and Wellness Landscape at 2.00pm on Wednesday July 30.
Morris believes the key to better health care could already be in your pocket, with doctors soon set to prescribe iPhone apps, instead of pills.
Technology will revolutionise the health industry - a paradigm shift from healthcare to personal wellness.
Health and wellness applications on smartphones are already big news, and are dramatically changing the way we manage our personal health and everyday wellness.

read more
open full screen

Generation and Application of Community Pharmacy Research

Neil Johnston

Editor’s Note: We have had a number of articles in this issue relating to pharmacy research.
The PGA has conducted a number of research initiatives over the years, including one recently reported in Pharmacy News that resulted from an analysis of the QCPP Patient Questionnaire.
Pharmacy Guild president, George Tambassis, appears to have authored the article following, and there also appears to be a disconnect between the survey report and its target audience illustrated by one of the respondent comments published.
I have asked Mark Coleman to follow through, elaborate and comment:

read more
open full screen

NPS Media Releases February 2010

NPS Spokesperson

articles by this author...

Regular information provided by NPS – Better choices, better health - NPS enables people to be medicinewise.

The National Prescribing Service (NPS) is a valued independent resource for accurate, evidence-based prescribing information and education.

Given the marketing pressures applied by global drug companies, NPS plays a vital and unique role across the healthcare sector.

open this article full screen

22 February 2010

Women warned aspirin reports may be misleading

Recent research from the US suggests women who have been diagnosed with breast cancer may benefit from taking aspirin but the National Prescribing Service (NPS) warns people to talk to their health professional before self-medicating.

The study, published in the Journal of Clinical Oncology, has received significant media attention, with some reports suggesting aspirin could be a miracle treatment.

NPS CEO, Dr Lynn Weekes says such media reports are concerning and people should not underestimate the strength or effectiveness of a medicine just because it can be purchased without a prescription.

“Like all medicines, aspirin has benefits but it also has potential harms. Aspirin is a salicylate drug, commonly used to relieve minor aches and pains, reduce fever, and as an anti-inflammatory agent,” Dr Weekes said.

“Aspirin also has a blood-thinning effect and can therefore increase the risk of bleeding, which can be dangerous for people already taking anticoagulants. For people with asthma it can trigger attacks if they are sensitive to this type of medicine.”

“If you are taking other medicines, particularly cancer treatments, it’s important to always talk to your doctor before starting a new medicine. This includes medicines that can be bought without a prescription or from an outlet such as a supermarket where you will not receive clinical advice.”

The study was conducted on 4164 female registered nurses in the US with a diagnosis of breast cancer between 1976 and 2002.

Dr Weekes said the results may be not be generalised for all women and recommends people talk to their doctor or pharmacist about whether aspirin is the best medicine for their personal condition.

Consumers with questions about medicines can call the NPS Medicines Line on 1300 888 763 (Mon-Fri 9am-5pm EST) and talk to a pharmacist for the cost of a local call (mobiles may cost more).

16 February 2010

National Census revealing extent of medicines use problems

Preliminary data from the National Census of Medicines Use in Australia shows a significant number of adverse medicines events aren’t being reported to GPs and people are struggling to identify information sources they can easily understand.

The Census, being conducted by the National Prescribing Service (NPS) and University of Melbourne, focuses on how Australians use their medicines, including prescription, non-prescription and complementary medicines.

It is the first national census to survey what combinations of medicines people take, how people find information about medicines and whether they have experienced problems with their choices.

“We’re already seeing a breadth of medicines use issues experienced by Australians. Many of these issues can be solved, and the information collected in this Census will help us determine the best ways to do so,” NPS CEO Dr Lynn Weekes said.

Analysis of data collected so far shows:

* A significant number of participants are reporting it’s difficult to find information about medicines they understand

* More than half the participants have reported the volume of information sources about medicines makes it hard to know what is accurate

* Many participants who used a medicine in the past year reported a side effect, reaction or other problem with their medicines during this time

“Data from this Census will be integral to NPS programs over coming years and will assist other organisations in the health sector when developing new resources and programs for the community.”

“We are grateful to the over 1000 people who have participated in the Census so far and hope others who are invited to participate will realise the value of their contribution,” Dr Weekes said.

This Census began in July 2009 and involves people aged over 50 years. This final phase ends in March and the full results will be published later in the year. A second phase involving people aged 18-49 will begin later in 2010.

Consumers with questions about medicines can call the NPS Medicines Line on 1300 888 763 (Mon-Fri 9am-6pm EST) and talk to a pharmacist for the cost of a local call (mobiles may cost more).

People who experience an adverse medicines event can report this to the Adverse Medicines Events line on 1300 134 237, (Mon-Fri 9-5pm EST). Please note this is not an emergency service.

For further information visit www.nps.org.au/research/medicinescensus

15 FEBRUARY 2010

Register now for the National Medicines Symposium

Registrations are now open for the National Medicines Symposium, the prestigious biennial conference dedicated to addressing medicines use issues across the health sector.

Hosted by the National Prescribing Service, the Symposium brings together everyone working in the medicines space from health professionals to academics, consumer groups and policy makers.

“The medicines environment is constantly changing and the National Medicines Symposium presents doctors with a unique opportunity to hear firsthand about the latest developments in clinical practice and interventions,” NPS CEO Dr Lynn Weekes said.

“NMS is the only event which brings together all professions and industry groups involved with medicines. It provides those working at the coalface with an opportunity to share expertise and experience, and contribute and benefit from stimulating discussions.”

“National and international speakers headline an exciting scientific program examining medicine in people’s lives, safe and judicious medicines use, and the changing role of prescribers,” Dr Weekes said.

The international guest speakers are:

Dr Eva Ombaka, recipient of the 2007 Olle Hansson award for her work in rational use of medicines, has been an international advocate for access to medicines and a pharmacist for 34 years.

Professor Munir Pirmohamed, NHS Chair of Pharmacogenetics in the UK, who will look at the role of pharmacogenetics in individualising medication therapy.

Dr Victor Montori, a diabetologist and clinical epidemiologist and Professor of Medicine at the Mayo Clinic College of Medicine in the US, will explore the treatment burden in complex chronic illness and the role of decision aids in clinical practice.

Among the many key national industry speakers will be:

· Dr Emil Djakic, Chair, Australian General Practice Network

· Prof Andrew McLachlan, Chair of Australia’s National Medicines Policy Committee

· Prof Peter Brooks, Director of the Australian Health Workforce Institute

Health professionals are invited to submit abstracts for oral presentation or poster display during the Symposium. Topics may cover clinical practice, education, research, complementary medicines, leadership, policy, innovations or future directions for quality use of medicines and must address the theme, Medicine in people’s lives.

Abstracts close 17 February 2010. The Symposium runs from 26-28 May at the Melbourne Conference & Exhibition Centre. For further information visit www.nms2010.org.au.

11 February 2010

NPS offering more and reaching wider audiences: report

Awareness of the National Prescribing Service (NPS) and utilisation of its products and services increased significantly over 2005–09, according to the latest NPS evaluation report.

Released today, the 2008–09 Evaluation Report No. 12 shows NPS continues to positively influence prescribing practice and medicines use through expanding its reach and relevance amongst the Australian population, health professionals and health professional students.

“This 12th evaluation report demonstrates the value of NPS in contributing to better health outcomes for Australians as well as helping to ensure the ongoing viability of the pharmaceutical benefits scheme,” NPS CEO, Dr Lynn Weekes said.

“GP participation remains high with around 60% of the GP workforce participating in at least one NPS activity, while pharmacist participation rates have increased significantly to 21% of registered pharmacists. Also, the number of nurses has nearly doubled to 2504, which is particularly encouraging given the key and growing role of nurses in quality use of medicines.”

“Notably, through our drug utilisation activities NPS has contributed to improved prescribing rates of analgesics and proton pump inhibitors including decreased prescribing of COX-2 selective NSAIDs, tramadol and high dose PPIs, and increased prescribing of low dose PPIs.”

Key achievements highlighted in the 2008–09 report include:

§ Total savings of $45.9 million to the PBS

§ Decrease in prescribing of COX-2 selective NSAIDs by 3.24 scripts per 1000 consultations where NPS had reached approximately 52% of GPs.

§ Decrease in prescribing of tramadol by 7.71 scripts per 1000 consultations where NPS had reached approximately 54% of GPs.

§ Decrease in prescribing of high dose PPIs by 10.36 scripts per 1000 consultations where the NPS interventions had reached approximately 30% of GPs.

§ The number of universities using our National Prescribing Curriculum has nearly doubled to 23 institutions across Australia

§ 27% of all Australians aged 15 years and older, and 32% of Australians aged 50 years and older are aware of NPS.

§ A total of 959 sessions were conducted with a total of 21,468 attendees across Australia through the Seniors Peer Education program.

§ An increase in the number of web page views of Australian Prescriber per month from 151,339 during 2007-08 to 241,834 during 2008-09.

§ 425,299 Medicine List resources were distributed in English and four other languages.

“Over the next 12 months we will continue to build on these achievements with programs focusing on hypnotic use and opioids, and we will expand our work with diverse audiences to ensure that all Australians have access to the same accurate information about medicines,” Dr Weekes said.

To view the full report go to www.nps.org.au/eval_report_12

10 February 2010

Time to think about vaccinations again

Vaccinations are usually associated with young children or travelling overseas, but immunisations given at childhood can wear off and leave adults exposed to debilitating diseases.

In the latest edition of MedicinesTalk, the National Prescribing Service (NPS) urges parents and grandparents to discuss their own vaccination needs with their doctor when taking children to get their shots.

“The need for vaccinations is not confined to children,” NPS CEO Dr Lynn Weekes said.

“People aged over 50 may benefit from being vaccinated against diseases like flu, pneumococcal disease and shingles. They may also benefit from having boosters of vaccinations like hepatitis, whooping cough, tetanus and diphtheria, which may have lost their efficacy.”

Vaccinations not only protect us from infectious diseases that can cause illness, disability and death but they also protect the community as a whole by reducing the number of people who contract these diseases and pass them on.

“The most beneficial vaccinations for you will depend on your age, health and lifestyle. Talk to your doctor about what you may need to have and how frequently they should be taken – for some it’s every year, for others it might be every 10 years. Keep a record somewhere and ensure you follow up when it’s time,” Dr Weekes said.

It is particularly important those at higher risk of some illnesses keep their vaccinations up to date. These include:

· People aged over 60

· People who smoke or who are overweight

· People with an existing chronic disease or compromised immune system

· Aboriginal and Torres Strait Islander peoples

For more information about vaccinations read the latest issue of MedicinesTalk at www.nps.org.au/consumers/publications/medicines_talk.

3 February 2010

New clinical program addresses sleep problems and therapy options

The latest NPS education program ‘Management options to maximise sleep’ encourages prescribers to recommend non-drug therapies as first-line treatment for insomnia and to discuss the importance of good sleep practices and the potential harms of hypnotic medicines with the patient before prescribing hypnotics.

BEACH data from 2006-08 shows medication was prescribed for 95.2 per 100 insomnia problems*, however research from the Agency for Healthcare Research and Quality in the US has shown non-drug therapies have comparable effectiveness to hypnotic medicines.

“Insomnia is often a secondary health issue caused by identifiable stressors, a medical or psychiatric condition, poor sleep practice and medicine or substance use,” NPS senior clinical adviser, Judith Mackson said.

“As well as addressing insomnia, identifying and addressing the cause may eliminate the need for hypnotics. For many people rectifying poor sleep practices will make a huge difference to the quality of their sleep.”

As well as comparable effectiveness, non-drug therapies do not carry the same potential adverse effects or dependency risks as hypnotics.

The ‘Management options to maximise sleep’ program encourages health professionals to:

* Explore patient concerns with sleep difficulties – identify and address causes

* Offer behavioural and cognitive therapies for insomnia

* Discuss and specify the duration of hypnotic medicines use

* Trial discontinuing hypnotic medicines in patients who have been using them for long periods

* Engage patient/carers in managing sleep difficulties

“There is particularly high use of hypnotic medicine in the elderly, yet this group is more at risk of adverse events. For patients who have been taking hypnotics for a prolonged time, prescribers are encouraged to develop plans to decrease their dose and review progress through the GP clinical audit tool provided by NPS as part of this program,” Ms Mackson said.

In cases where drug treatment cannot be avoided, as non-drug therapies alone are not effective, patients should be prescribed the lowest effective dose for the shortest duration and educated on the adverse effects of hypnotic medicines. Initial prescriptions should be limited to less than ten days.

The NPS has developed the following resources and activities about managing insomnia for health professionals:

· NPS News (67): Addressing hypnotic medicines use in primary care

· Prescribing Practice Review (49): Management options for improving slee

* GP and GP Registrar Clinical Audit - Use of benzodiazepines, zolpidem and zopiclone in insomnia

* Case study (62): Maximising sleep and minimising potential harms

· Drug Use Evaluation (DUE) tool: Benzodiazepine and non-benzodiazepine hypnotic medicines for insomnia in aged care facilities

· One-on-one educational visiting by NPS facilitators

· Small group discussions led by NPS facilitators

For further information visit www.nps.org.au/health_professionals.

Media enquiries to Katie Butt, NPS Media Adviser, 02 8217 8667 or kbutt@nps.org.au

Return to home

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
This question is for testing whether you are a genuine visitor, to prevent automated spam submissions.
Incorrect please try again
Enter the words above: Enter the numbers you hear:

health news headlines provided courtesy of Medical News Today.

Click here to read more...

If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.

Subscribe to our mailing list

Email Format
 

 

  • Copyright (C) 2000-2019 Computachem Services, All Rights Reserved.

Website by Ablecode